Legend Biotech (LEGN) EBIT (2019 - 2025)
Legend Biotech (LEGN) posted EBIT of -$19.7 million for Q4 2025, up 54.66% on a QoQ basis from -$43.5 million in Q3 2025, and up 75.16% year-over-year from -$11.2 million in Q4 2024.
Legend Biotech (LEGN) EBIT (2019 - 2025) Analysis & Trends
Legend Biotech's EBIT history runs 7 years deep, the most recent figure standing at -$19.7 million for Q4 2025.
- Quarterly EBIT rose 75.16% year-over-year to -$19.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$297.4 million (down 24.75% YoY) and the FY2025 annual result came in at -$136.5 million, up 55.9% from the prior year.
- EBIT was -$19.7 million for Q4 2025 at Legend Biotech, up from -$43.5 million in the prior quarter.
- Across five years, EBIT topped out at -$56603.0 in Q1 2021 and bottomed at -$204.0 million in Q2 2023.
- A 5-year average of -$93.6 million and a median of -$91.2 million in 2021 frame the typical range for EBIT.
- Annual changes were most pronounced in 2021 — EBIT soared 99.89% — and 2022, when it tumbled 58501.13%.
- Legend Biotech's EBIT stood at -$88.9 million in 2021, then plunged by 58.07% to -$140.6 million in 2022, then decreased by 4.43% to -$146.8 million in 2023, then soared by 45.99% to -$79.3 million in 2024, then surged by 75.16% to -$19.7 million in 2025.
- Business Quant data shows LEGN's EBIT at -$19.7 million in Q4 2025, -$43.5 million in Q3 2025, and -$130.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -19.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.70 Mn |
| Sep 30, 2025 | -43.45 Mn |
| Jun 30, 2025 | -130.02 Mn |
| Mar 31, 2025 | -104.19 Mn |
| Dec 31, 2024 | -79.30 Mn |
| Sep 30, 2024 | -70.36 Mn |
| Jun 30, 2024 | -23.45 Mn |
| Mar 31, 2024 | -65.26 Mn |
| Dec 31, 2023 | -146.82 Mn |
| Sep 30, 2023 | -36.22 Mn |
| Jun 30, 2023 | -204.02 Mn |
| Mar 31, 2023 | -106.86 Mn |
| Dec 31, 2022 | -140.58 Mn |
| Sep 30, 2022 | -93.43 Mn |
| Jun 30, 2022 | -189.34 Mn |
| Mar 31, 2022 | -33.17 Mn |
| Dec 31, 2021 | -88.94 Mn |
| Sep 30, 2021 | -124.96 Mn |
| Jun 30, 2021 | -172.48 Mn |
| Mar 31, 2021 | -56,603.00 |